Committee, (The First) Vice Chairman of the Board of Directors and Chief Executive Officer 3. Mr. Sontiyan Chuenruetainaidhama (The Second) Vice Chairman of the Board of Directors 4. Mr. Somchai Meesen
progressed 62.79% (The construction plan was 62.55%). The commercial operation date is scheduled in the second quarter of 2022. Page 3 1.2 Additional Investments in Joint Ventures - On September 25, 2019, EGCO
tender offer period will be of 45 business days and the delisting process is expected to be completed by December 2019. GLOW Acquisition and Accounting Record Note: 1. In the second quarter of 2019, the
of intangible asset from the acquisition of GLOW 2. From the second quarter of 2019, the company has changed the classification of operating income and cost of sales resultin g in the operating income
recorded expected credit loss of 1,345 million baht, decreasing by 25% y-y and 15% q-q. Net credit cost was at 6.6% declined from 7.6% in the second quarter of 2020 as we implemented more conservative credit
1 2Q21 MD&A Advanced Info Service Plc. Executive Summary Prolonged economic impact from new phase of pandemic in 2Q21 As the new phase of pandemic re-emerged in the second quarter, we observed the
Outlook TOWARD THE SECOND HALF OF 2021 In order to expand the variety of To-Go beverage products, the company has also released 3 new instant Thai herbal drinks which are fresh ginger juice, fresh galingale
main reason is increased from reversal of expected credit loss amounting Baht 22.44 million in the second quarter of this year. Financial Cost and Income Tax Expense For 3rd quarter of 2022, the Company
) ______________________ By virtue of Section 8, Section 12(3), Section 13, the second paragraph of Section 30, Section 37(4), Sub-clause (3) of the first Paragraph of Section 55, Section 56 and Section 58 of the Trust for
paid by 31 January of the year, except for the first year of business operation whereby the licensee shall pay the minimum fee on the first day of the business operation; (2) the second installment: the